XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating Activities:    
Net income $ 49,626 $ 22,256
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 40,085 38,531
Deferred income taxes 1,568 (3,017)
Stock based compensation 10,291 8,451
(Gain) loss on disposition of property and equipment (1,702) 873
Provisions for inventory 502 6,597
Impairment of goodwill   19,509
Other (1,057) 81
Changes in assets and liabilities:    
Accounts receivable, net (16,179) (19,813)
Inventory (27,826) 3,733
Other assets (35,959) (19,218)
Accounts payable 38,501 32,158
Other liabilities 15,239 (10,099)
Net cash provided by operating activities 73,089 80,042
Investing Activities:    
Purchases of property and equipment (50,354) (26,526)
Proceeds from the sale of property and equipment 7,537 72
Proceeds from deferred purchase price of factored receivables 10,266 10,139
Cost of technology investments (590) (630)
Net cash used in investing activities (33,141) (16,945)
Financing Activities:    
Borrowings on debt 53,000  
Repayments of debt (53,520) (27,166)
Proceeds from the exercise of Common Stock options 4,650 263
Taxes withheld and paid on employees' stock-based compensation (3,157) (2,754)
Cash paid for the repurchase of Common Stock (41,578) (31,094)
Net cash used in financing activities (40,605) (60,751)
Foreign currency effect 1,565 (1,883)
Net increase in cash and cash equivalents 908 463
Cash and cash equivalents at beginning of period 149,673 153,891
Cash and cash equivalents at end of period 150,581 154,354
Supplemental disclosure of cash flow information:    
Cash paid for taxes 19,470 18,893
Cash paid for interest 10,022 9,737
Non-Cash Investing Activities:    
Period-end balance of accounts payable for property and equipment 7,646 4,501
Deferred purchase price of receivables factored in the period $ 9,276 $ 11,344